Skip to content
The Bamboo Works
  • Categories
    • Featured Post
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • FinVolution
    • Huazhu
    • Pop Mart
    • Tuya
    • Weimob
    • Yalla
  • Expert Corner
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Register
  • 简中简中
  • 繁中繁中
  • EngEng
  • February 2, 2023
    Genscript Bio Gets Booster from Subsidiary’s New Cancer Drug
    The company’s Legend Biotech unit has found recent success with Carvykti, a...
    Healthcare/biotech 
  • February 2, 2023
    Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech
    The maker of G-protein-coupled receptor (GPCR) drugs will raise more than $100...
    Healthcare/biotech IPO 
  • February 1, 2023
    JL Mag Steps Up R&D Spending as Growth Slows
    The world’s top producer of rare earth magnetic materials said its revenue...
    Infrastructure/Resources New Energy 
  • February 1, 2023
    Fashion Retailer KK Group Stitches Up Revived IPO Plan
    The popular clothing chain operator has restarted its plan to list in...
    Consumer IPO 
  • January 31, 2023
    Luckin Comeback Percolates at Full Steam With Reported Global Expansion
    Media reports say the scandal-tainted coffee chain is looking to expand into...
    Consumer 
Genscript Bio Gets Booster from Subsidiary’s New Cancer Drug

Genscript Bio Gets Booster from...

February 2, 2023
Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech

Structure Therapeutics Hopes to Wow...

February 2, 2023
JL Mag Steps Up R&D Spending as Growth Slows

JL Mag Steps Up R&D...

February 1, 2023
Fashion Retailer KK Group Stitches Up Revived IPO Plan

Fashion Retailer KK Group Stitches...

February 1, 2023

Latest News

    gutentor-overlay

    Kappa’s China Franchisee Stumbles in Race for China Sportswear Market

    January 31, 2023
    Consumer
    China Dongxiang took a big hit from Covid last year, but has been gradually falling further beh…
    gutentor-overlay

    Sihuan Pharma’s Botox Beauty Bid Suffers Covid Wrinkle

    January 30, 2023
    Healthcare/biotech
    The cardiovascular and cancer drug maker’s recent shift to the medical beauty business was doin…
    gutentor-overlay

    New Ruipeng Trots Out ‘Pet Project’ IPO

    January 30, 2023
    Consumer, IPO
    China’s largest provider of pet products and services could raise as much as $400 million from …
    gutentor-overlay

    CHINA BULLETIN: Covid Cases Plunge as Year of the Rabbit Kicks Off

    January 29, 2023
    CHINA BULLETIN, Finance, IPO, New Energy, Social Media/Entertainment
    In this week’s issue Covid deaths plunge, Blizzard’s “World of Warcraft” bids farewell to Chine…
    gutentor-overlay

    361 Degrees Outruns Its Peers. Now It’s Waiting for Investors to Notice

    January 27, 2023
    Consumer
    Despite outperforming its rivals in fourth-quarter sales growth, the sportswear retailer still …
    gutentor-overlay

    Chinese Companies Raise Big Bucks in New York, Hong Kong

    January 27, 2023
    Ecommerce, Healthcare/biotech, IPO, Social Media/Entertainment
    Eight U.S.- and Hong Kong-listed Chinese companies have collectively raised more than $2 billio…
    Subscribe to Our Free eNewsletter

    Fast News

    FAST NEWS: Yidu Tech CEO Resigns, Replaced by Husband

    February 2, 2023

    FAST NEWS: Baozun Completes Acquisition of Gap China

    February 1, 2023

    FAST NEWS: Junshi Bio’s Loss Balloons on High R&D Spending

    January 31, 2023

    FAST NEWS: InnoCare Pharma’s Loss Soars on R&D Costs, Exchange Losses

    January 30, 2023

    FAST NEWS: Ascletis Pharma’s Monkeypox Drug Gets IND Approval

    January 27, 2023

    Follow us on your favorite platforms


    Benzinga

    IPO

    February 2, 2023

    Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech

    The maker of G-protein-coupled receptor (GPCR) drugs will raise more than $100 million in its IPO this week, making it the first major U.S. listing by a Chinese company this year Key Takeaways: By Doug Young The march of new Chinese IPOs in New York continues this week...
    Healthcare/biotech IPO 
    February 1, 2023

    Fashion Retailer KK Group Stitches Up Revived IPO Plan

    Consumer IPO 
    January 30, 2023

    New Ruipeng Trots Out ‘Pet Project’ IPO

    Consumer IPO 
    January 29, 2023

    CHINA BULLETIN: Covid Cases Plunge as Year of the Rabbit Kicks Off

    CHINA BULLETIN Finance IPO New Energy Social Media/Entertainment 
    January 27, 2023

    Chinese Companies Raise Big Bucks in New York, Hong Kong

    Ecommerce Healthcare/biotech IPO Social Media/Entertainment 
    January 20, 2023

    Chinese Liquor Distiller ZJLD Gives Hong Kong Listing a Shot

    Consumer IPO 
    January 20, 2023

    Autonomous Driving Tech Firm Hesai Takes Pole Position With U.S. IPO Application

    Infrastructure/Resources IPO 

    Consumer

    February 1, 2023

    Fashion Retailer KK Group Stitches Up Revived IPO Plan

    The popular clothing chain operator has restarted its plan to list in Hong Kong, seizing on hopes for China’s post-Covid economic recovery Key Takeaways: By Fai Pui A pair of sister brands have taken Chinese shopping malls by storm these last few years, their yellow and pink motifs...
    Consumer IPO 
    January 31, 2023

    Luckin Comeback Percolates at Full Steam With Reported Global Expansion

    Consumer 
    January 31, 2023

    Kappa’s China Franchisee Stumbles in Race for China Sportswear Market

    Consumer 
    January 30, 2023

    New Ruipeng Trots Out ‘Pet Project’ IPO

    Consumer IPO 
    January 27, 2023

    361 Degrees Outruns Its Peers. Now It’s Waiting for Investors to Notice

    Consumer 
    January 20, 2023

    Chinese Liquor Distiller ZJLD Gives Hong Kong Listing a Shot

    Consumer IPO 
    January 18, 2023

    Uxin Opens Upgraded Superstore in Race to Prove New Business Model

    Consumer 

    Ecommerce

    January 27, 2023

    Chinese Companies Raise Big Bucks in New York, Hong Kong

    Eight U.S.- and Hong Kong-listed Chinese companies have collectively raised more than $2 billion this month, mostly through new share issues Key Takeaways: By Doug Young Long-suffering U.S.- and Hong Kong-listed Chinese companies are taking advantage of recent positive sentiment to raise billions of dollars, bringing new meaning...
    Ecommerce Healthcare/biotech IPO Social Media/Entertainment 
    January 26, 2023

    Koolearn’s New Lesson: E-Commerce Pays Better Than Education

    Ecommerce Education 
    January 18, 2023

    Ant Group Tipped to Revive IPO Plans after Jack Ma Bows Out

    Ecommerce Finance 
    January 13, 2023

    Healthcare Overtakes New Energy as Top Category for Chinese Concept Stocks in 2022: Bamboo Works Special Report

    Consumer Ecommerce Education Finance Healthcare/biotech Infrastructure/Resources IPO New Energy Social Media/Entertainment 
    January 10, 2023

    Weimob to Raise $205 Million in Campaign to Jumpstart Growth

    Ecommerce 
    January 6, 2023

    Dada Delivers Big Returns as U.S. Investors Return to China Stocks

    Consumer Ecommerce 
    January 3, 2023

    Secoo’s Contraction Slows as It Cleans Up Financial House

    Consumer Ecommerce 

    Healthcare/Biotech

    February 2, 2023

    Genscript Bio Gets Booster from Subsidiary’s New Cancer Drug

    The company’s Legend Biotech unit has found recent success with Carvykti, a chimeric antigen receptor T-cell (CAR-T) therapy, which earned $134 million in its first nine months on the market Key Takeaways: By Emily Chan The good news is coming thick and fast these days for Genscript Biotech...
    Healthcare/biotech 
    February 2, 2023

    Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech

    Healthcare/biotech IPO 
    January 30, 2023

    Sihuan Pharma’s Botox Beauty Bid Suffers Covid Wrinkle

    Healthcare/biotech 
    January 27, 2023

    Chinese Companies Raise Big Bucks in New York, Hong Kong

    Ecommerce Healthcare/biotech IPO Social Media/Entertainment 
    January 19, 2023

    Charged by Surgical Robot’s Approval, Shenzhen Edge Medical Makes New IPO Bid

    Healthcare/biotech IPO 
    January 17, 2023

    Riding Covid Vaccine Highs, CanSino Plans Swiss Listing

    Healthcare/biotech 
    January 13, 2023

    Healthcare Overtakes New Energy as Top Category for Chinese Concept Stocks in 2022: Bamboo Works Special Report

    Consumer Ecommerce Education Finance Healthcare/biotech Infrastructure/Resources IPO New Energy Social Media/Entertainment 

    About Us

    The Bamboo Works

    Bamboo Works offers a range of partnerships for corporate and other partners, including opportunities for sponsored content, article-writing services and a wide range of promotions.

    For individual queries, please contact us by clicking here.

    Copyright © 2022 Bamboo Works. All rights reserved. Powered by Ideo Concepts.

    Proudly powered by WordPress | Theme: SuperMag by Acme Themes
    Posting....
    Scroll Up